ACLY and fatty liver disease: Thus, in leptin receptor-deficient mice, knocking down hepatic ACLY expression protected against hepatic steatosis [10], whereas hepatic ACLY abrogation increased TG levels in the liver in wild-type mice fed either a low-fat or a high-fat diet [11].